Salicylic Acid

Phase 2Small molecule

HHadassah Medical Organization

Salicylic Acid is one of 47 small molecule programs targeting Keratosis. It is currently in Phase 2.

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[3][1]

Indication

KeratosisActive, not recruiting

PsoriasisActive, not recruiting

Plantar WartActive, not recruiting

KeratosisPhase 2

Active, not recruiting

PsoriasisPhase 2

Active, not recruiting

Plantar WartPhase 2/Phase 3

Active, not recruiting

Competition

Competitive Landscape

605 competitors in Psoriasis

#DrugCompanyPhaseTrials

Cosentyx

Novartis

Preclinical

53 2

Stelara

Johnson & Johnson

Preclinical

37 3

Taltz

Eli Lilly

Preclinical

20 4

Humira

CCelltrion

Preclinical

42 5

Ilumya

Sun Pharmaceutical Industries, Inc.

Preclinical

15 6

Raptiva

Roche

Preclinical

10 7

Remicade

OOrganon and Co

Preclinical

20 8

Siliq

BBausch Health Americas, Inc.

Preclinical

14 9

Victoza

Novo Nordisk

Preclinical

2 10

Lovenox

Sanofi

Preclinical

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Timeline

Expected Milestones

Q2 2027

Phase 1Not yet recruiting

Cutaneous Warts

NCT07396714

Clinical

Trials by Indication[1]

Keratosis2 trials

Effects of Leaf Extract of Azadirachta Indica in Palmer Arsenical Keratosis

Completed·—·N/A·NCT01731756·50 enrolled

Effect of Neem Extract, Propylene Glycol and Salicylic Acid Combination in the Treatment of Arsenical Palmar Keratosis

Completed·—·Phase 2·NCT02352987·30 enrolled

Plantar Wart1 trial

Pyruvic Acid Versus Salicylic Acid Preparation in Treatment of Plantar Warts

Unknown status·IIsfahan University of Medical Sciences·Phase 2/3·NCT02151630·60 enrolled

Psoriasis1 trial

Parallel Group Trial to Evaluate the Efficacy and Safety of Loion® Compared to 10% Salicylic Acid in Patients With Chronic Psoriasis Capitis

Completed·GG. Pohl-Boskamp GmbH & Co. KG·Phase 2·NCT01914627·90 enrolled

Efficacy and Safety1 trial

Efficacy and Safety of a Preparation Containing an Antibiotic and Anti-Inflammatory Agent in Acne Vulgaris

Completed·HHadassah Medical Organization·Phase 1/2·NCT00361322·40 enrolled

Cutaneous Warts1 trial

the Efficacy of Ivermectin Alone or With Microneedling in Treatment of Cutaneous Warts.

Not yet recruiting·—·Phase 1·NCT07396714·88 enrolled

1 more indication

Treatment1 trial

Anti-acne Efficacy of a Dermo-cosmetic Product Associated With the Fixed Combination Adapalene 0.1%/ Benzoyl Peroxide 2.5% Treatment Versus This Treatment Associated With a Standard Moisturizer in Male and Female Subjects Presenting With Mild to Moderate Acne

Completed·VVichy Laboratoires·Phase 4·NCT03832647·200 enrolled

Sources

References

[1]
ClinicalTrials.gov — 7 trial records for Salicylic Acid. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — Salicylic Acid compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for Salicylic Acid. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — Hadassah Medical Organization company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Phase 2[1]
Company: HHadassah Medical Organization

Salicylic Acid

Status by Indication[3][1]

Competitive Landscape

Expected Milestones

Q2 2027

Trials by Indication[1]

Keratosis2 trials

Plantar Wart1 trial

Psoriasis1 trial

Efficacy and Safety1 trial

Cutaneous Warts1 trial

Treatment1 trial

References

Drug Info

Quick Facts

Related News